175 related articles for article (PubMed ID: 25838280)
1. CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation.
Bonzheim I; Mankel B; Klapthor P; Schmidt J; Hinrichsen T; Wachter O; Fend F; Quintanilla-Martinez L
Blood; 2015 Apr; 125(14):2309-11. PubMed ID: 25838280
[No Abstract] [Full Text] [Related]
2. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.
Xia D; Hsi ED; Dal Cin P; Hasserjian RP
Am J Hematol; 2019 Apr; 94(4):504-505. PubMed ID: 30105753
[No Abstract] [Full Text] [Related]
3. Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.
da Costa VEF; de Oliveira RD; Traina F; Chahud F; Palma LC; de Figueiredo-Pontes LL
Br J Haematol; 2020 Feb; 188(3):e21-e23. PubMed ID: 31681999
[No Abstract] [Full Text] [Related]
4. Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.
Liu C; Hu R; Du Z; Abecasis M; Wang C
Medicine (Baltimore); 2020 Jan; 99(5):e18811. PubMed ID: 32000382
[TBL] [Abstract][Full Text] [Related]
5. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
Diamond JM; de Almeida AM; Belo HJ; da Costa MP; Cabeçadas JM; Abecasis MM
Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446
[No Abstract] [Full Text] [Related]
6. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
Turakhia SK; Murugesan G; Cotta CV; Theil KS
J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
[TBL] [Abstract][Full Text] [Related]
8. A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia.
Rubinstein R; Purves LR
Leukemia; 1998 Feb; 12(2):230-2. PubMed ID: 9519786
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of BCR-ABL1-positive chronic myeloid leukemia following essential thrombocythemia.
Weng WH; Shih LY
Acta Haematol; 2011; 126(4):220-3. PubMed ID: 21934297
[No Abstract] [Full Text] [Related]
11. Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Kang MG; Choi HW; Lee JH; Choi YJ; Choi HJ; Shin JH; Suh SP; Szardenings M; Kim HR; Shin MG
Oncotarget; 2016 Aug; 7(35):57036-57049. PubMed ID: 27486987
[TBL] [Abstract][Full Text] [Related]
12. [A case of chronic myeloid leukemia with positive CALR gene].
Han Y; Song Y; Wang Y; Chai Y; Zeng PY; Yue LL; Wu CY
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):872. PubMed ID: 33190451
[No Abstract] [Full Text] [Related]
13. Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.
Al Assaf C; Van Obbergh F; Billiet J; Lierman E; Devos T; Graux C; Hervent AS; Emmerechts J; Tousseyn T; De Paepe P; Papadopoulos P; Michaux L; Vandenberghe P
Haematologica; 2015 Jul; 100(7):893-7. PubMed ID: 25934766
[TBL] [Abstract][Full Text] [Related]
14. A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm.
Cabagnols X; Cayuela JM; Vainchenker W
N Engl J Med; 2015 Feb; 372(7):688-90. PubMed ID: 25671272
[No Abstract] [Full Text] [Related]
15. A rare CALR variant mutation and a review of CALR in essential thrombocythemia.
Diep R; Metjian A
J Thromb Thrombolysis; 2018 Apr; 45(3):457-462. PubMed ID: 29411299
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin mutation burden--is it a stable clone in patients with essential thrombocythemia and myelofibrosis?
Shuly Y; Nagar M; Ben-Asaf L; Kneller A; Steinberg DM; Amariglio N; Salomon O
Blood Cells Mol Dis; 2015 Dec; 55(4):281-3. PubMed ID: 26460248
[TBL] [Abstract][Full Text] [Related]
17. Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia.
Grisouard J; Ojeda-Uribe M; Looser R; Hao-Shen H; Lundberg P; Duek A; Jeandidier E; Karow A; Skoda RC
Blood; 2013 Nov; 122(22):3694-6. PubMed ID: 24263960
[No Abstract] [Full Text] [Related]
18. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
19. Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Limsuwanachot N; Rerkamnuaychoke B; Chuncharunee S; Pauwilai T; Singdong R; Rujirachaivej P; Chareonsirisuthigul T; Siriboonpiputtana T
Hematology; 2017 Dec; 22(10):599-606. PubMed ID: 28406068
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetics and molecular studies confirm the histopathologic diagnosis of chronic myeloproliferative diseases].
Werner M; Nolte M; Ewing M; Kaloutsi V; Kausche F; Georgii A
Pathologe; 1995 Jan; 16(1):41-5. PubMed ID: 7886013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]